NCT03072316

Brief Summary

The investigators intend to undertake a study to investigate the effect of radiotherapy on deep inferior epigastric perforator flap reconstructions (DIEP). Adjuvant post-mastectomy radiotherapy (PMRT) is offered to women at high risk of chest wall recurrence. The perceived detrimental effect of radiotherapy on an immediate breast reconstruction and the "one-off" nature of autologous reconstruction leads some surgeons to recommend delayed reconstruction after mastectomy or to use a temporising implant with a view to planned exchange to autologous reconstruction after radiotherapy. However, there remains significant uncertainty in the literature about the impact of radiotherapy on autologous reconstructions. This study is a mixed methology study using patient reported outcome measures (PROMS), applanation tonometry (measure of breast compressibility), semi-structured interviews and 3 dimensional photography analysis to compare the aesthetic and impact on quality of life on the following groups of patients: Patient groups:

  1. 1.Unilateral skin sparing mastectomy (SSM) with immediate DIEP flap reconstruction and PMRT (cases)
  2. 2.Unilateral SSM with immediate DIEP flap reconstruction and no PMRT (controls)
  3. 3.Unilateral simple mastectomy, PMRT, and subsequent delayed DIEP flap reconstruction (controls)
  4. 4.Unilateral SSM with temporizing implant, PMRT and subsequent conversion to DIEP (controls)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2015

Completed
9 months until next milestone

Study Start

First participant enrolled

January 14, 2016

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2018

Completed
Last Updated

April 4, 2017

Status Verified

March 1, 2017

Enrollment Period

2 years

First QC Date

April 13, 2015

Last Update Submit

March 31, 2017

Conditions

Keywords

breast cancermastectomydeep inferior perforator flap reconstructionpost mastectomy radiotherapy

Outcome Measures

Primary Outcomes (1)

  • The difference in patient satisfaction score between patients with an irradiated DIEP flap (group (a)) and patients with a DIEP flap who have not undergone PMRT (group (b)) using "satisfaction with reconstructed breast" question of the BREAST-Q.

    The difference in (mean or median) patient satisfaction score (ranging from 0-100) between patients with an irradiated DIEP flap (group (a)) and patients with a DIEP flap who have not undergone PMRT (group (b)) using the "satisfaction with reconstructed breast" subscale of the postoperative reconstruction module of the BREAST-Q questionnaire.

    Day 1

Secondary Outcomes (11)

  • The difference in scores in other subscales from the BREAST-Q questionnaire between patients with an irradiated DIEP flap (group (a)) and patients with a DIEP flap who have not undergone PMRT (group (b)).

    Day 1

  • The difference in patient satisfaction and all subscales between patients with an irradiated DIEP flap (group (a)) and patients who underwent PMRT prior to DIEP flap (group (c) and group (d)) using BREAST-Q scores as above.

    Day 1

  • Volume and symmetry assessment of the reconstructed breast using 3D surface imaging This would consist of comparing volume and symmetry assessment between groups (a) and (b), groups (a) and (c), and groups (a) and (d).

    Day 1

  • Panel assessment by independent panel of the reconstruction using 3D surface imaging.

    Day 1

  • Applanation tonometry for assessment of the consistency of the reconstructed breast. This will consist of comparing breast compressibility in the reconstructed breast between groups (a) and (b), groups (a) and (c), and groups (a) and (d).

    Day 1

  • +6 more secondary outcomes

Study Arms (4)

SSM immediate DIEP

Unilateral skin sparing mastectomy with immediate DIEP

Other: 3D surface imagingOther: semi-structured interviewOther: applanation tonometry

SSM immediate DIEP and PMRT

Unilateral skin sparing mastectomy with immediate DIEP flap reconstruction and post mastectomy radiotherapy

Other: 3D surface imagingOther: semi-structured interviewOther: applanation tonometry

mastectomy, PMRT, delayed DIEP

simple mastectomy, post mastectomy radiotherapy adn then delayed DIEP reconstruction

Other: 3D surface imagingOther: semi-structured interviewOther: applanation tonometry

SSM, temporizing implant, PMRT then DIEP

Unilateral SSM with temporizing implant, PMRT and subsequent

Other: 3D surface imagingOther: semi-structured interviewOther: applanation tonometry

Interventions

3D photography

SSM immediate DIEPSSM immediate DIEP and PMRTSSM, temporizing implant, PMRT then DIEPmastectomy, PMRT, delayed DIEP

qualitative analysis using semi structured interview

SSM immediate DIEPSSM immediate DIEP and PMRTSSM, temporizing implant, PMRT then DIEPmastectomy, PMRT, delayed DIEP

measurement of breast compressibility

SSM immediate DIEPSSM immediate DIEP and PMRTSSM, temporizing implant, PMRT then DIEPmastectomy, PMRT, delayed DIEP

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient who has undergone unilateral DIEP reconstruction for breast cancer at the Royal Marsden NHS Foundation Trust

You may qualify if:

  • Women who have undergone one of the treatment sequences above (a) - (d)
  • Patient groups:
  • Unilateral skin sparing mastectomy (SSM) with immediate DIEP flap reconstruction and PMRT (cases)
  • Unilateral SSM with immediate DIEP flap reconstruction and no PMRT (controls)
  • Unilateral simple mastectomy, PMRT, and subsequent delayed DIEP flap reconstruction (controls)
  • Unilateral SSM with temporizing implant, PMRT and subsequent conversion to DIEP (controls)
  • Patients of any age will be included
  • Patients who are between one and five years post initial breast reconstruction surgery or radiotherapy (which ever is most recent)

You may not qualify if:

  • Women who have undergone bilateral mastectomy, even if the contralateral mastectomy was asynchronous.
  • Women who are less than one year from their last radiotherapy treatment or from their DIEP flap reconstruction.
  • Patients who have had more than one implant based operation before DIEP flap (revision surgery to the implant implies that an implant based reconstruction was the primary intent and therefore the DIEP flap is a 'salvage' procedure) or if it is documented to be a salvage reconstruction.
  • Women who have developed recurrent / distant disease.
  • Women who are unable to stand for the 3D imaging (approximately 10 minutes)
  • Women who are unable to complete the English language questionnaire or interview (i.e. learning difficulties or patients who do not have adequate English language skills).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Marsden NHS Foundation Trust

London, London, SW3 6JJ, United Kingdom

RECRUITING

Related Publications (1)

  • O'Connell RL, Di Micco R, Khabra K, Kirby AM, Harris PA, James SE, Power K, Ramsey KWD, Rusby JE. Comparison of Immediate versus Delayed DIEP Flap Reconstruction in Women Who Require Postmastectomy Radiotherapy. Plast Reconstr Surg. 2018 Sep;142(3):594-605. doi: 10.1097/PRS.0000000000004676.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Jennifer Rusby, DM FRCS

    The Royal Marsden Hospital NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rachel O'Connell, MBBSBScMRCS

CONTACT

Jennifer Rusby, DM FRCS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2015

First Posted

March 7, 2017

Study Start

January 14, 2016

Primary Completion

January 14, 2018

Study Completion

January 14, 2018

Last Updated

April 4, 2017

Record last verified: 2017-03

Locations